Ingalls & Snyder LLC Viatris Inc Transaction History
Ingalls & Snyder LLC
- $2.55 Billion
- Q4 2024
A detailed history of Ingalls & Snyder LLC transactions in Viatris Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 221,515 shares of VTRS stock, worth $2.38 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
221,515
Previous 193,874
14.26%
Holding current value
$2.38 Million
Previous $2.25 Million
22.52%
% of portfolio
0.11%
Previous 0.09%
Shares
17 transactions
Others Institutions Holding VTRS
# of Institutions
1,106Shares Held
967MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.51 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$994 Million0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$677 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$671 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$523 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...